P035 ETROLIZUMAB TREATMENT MODULATES SOLUBLE MADCAM-1 LEVELS IN SERUM IN PATIENTS WITH CROHN’S DISEASE

Authors :: Wenhui Zhang
Julián Panés
Rhian Jacob
Franklin Fuh
William J. Sandborn
Rich Erickson
Jacqueline McBride
Meina T. Tang
Source :: Inflammatory Bowel Diseases. 25:S17-S17
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: Crohn's disease
Hepatology
medicine.diagnostic_test
medicine.drug_class
Cadherin
business.industry
Gastroenterology
Mucous membrane
medicine.disease
Monoclonal antibody
Ulcerative colitis
Flow cytometry
medicine.anatomical_structure
Etrolizumab
Immunology
medicine
Immunology and Allergy
business
Whole blood

Tools